[144] Vita Coco Company, Inc. SEC Filing
Rhea-AI Filing Summary
Vita Coco Company, Inc. (COCO) notice records a proposed sale under Rule 144 and recent 10b5-1 transactions by an insider. The filer plans to sell 20,000 common shares through Morgan Stanley Smith Barney at an aggregate market value of $799,600, representing securities outstanding of 56,822,981 shares, with an approximate sale date of 09/17/2025.
The securities were acquired on 09/17/2025 by exercise of stock options and paid in cash. The filing also discloses two prior 10b5-1 sales this year: 10,000 shares on 07/07/2025 for $380,178 and 10,000 shares on 09/12/2025 for $400,019.
Positive
- Full disclosure of transaction details including dates, amounts, broker, and aggregate market value
- Prior 10b5-1 sales disclosed, indicating planned trading activity rather than ad hoc insider sales
- Cash payment on option exercise is stated, clarifying consideration for the acquisition
Negative
- None.
Insights
TL;DR: Insider exercised options and intends to sell 20,000 shares (~$800k); prior 10b5-1 sales occurred earlier in 2025.
This Form 144 documents a routine insider sale following option exercise and existing 10b5-1 plans. The size of the proposed sale is small relative to the reported 56.8 million shares outstanding, suggesting limited dilution or market impact. The filing confirms cash payment on exercise and provides dates and values for two recent 10b5-1 transactions, which supports a pattern of planned sales rather than opportunistic trading.
TL;DR: Disclosure aligns with Rule 144 requirements; signatures and representations about material nonpublic information are included.
The notice includes the required representation that the seller is unaware of undisclosed material adverse information and references reliance on Rule 10b5-1 where applicable. This procedural compliance is important for governance and insider trading controls. No departures from standard disclosure practices are evident in the content provided.